Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine

Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect. Immun. 76:1143-1152, 2008). Here, mice were precolonized with any of three human co...

Full description

Saved in:
Bibliographic Details
Published inInfection and Immunity Vol. 77; no. 7; pp. 2876 - 2886
Main Authors Leatham, Mary P, Banerjee, Swati, Autieri, Steven M, Mercado-Lubo, Regino, Conway, Tyrrell, Cohen, Paul S
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.07.2009
American Society for Microbiology (ASM)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect. Immun. 76:1143-1152, 2008). Here, mice were precolonized with any of three human commensal strains (E. coli MG1655, E. coli HS, or E. coli Nissle 1917) and 10 days later were fed 10⁵ CFU of the same strains. While each precolonized strain nearly eliminated its isogenic strain, confirming that colonization resistance can be modeled in mice, each allowed growth of the other commensal strains to higher numbers, consistent with different commensal E. coli strains using different nutrients in the intestine. Mice were also precolonized with any of five commensal E. coli strains for 10 days and then were fed 10⁵ CFU of E. coli EDL933, an O157:H7 pathogen. E. coli Nissle 1917 and E. coli EFC1 limited growth of E. coli EDL933 in the intestine (10³ to 10⁴ CFU/gram of feces), whereas E. coli MG1655, E. coli HS, and E. coli EFC2 allowed growth to higher numbers (10⁶ to 10⁷ CFU/gram of feces). Importantly, when E. coli EDL933 was fed to mice previously co-colonized with three E. coli strains (MG1655, HS, and Nissle 1917), it was eliminated from the intestine (<10 CFU/gram of feces). These results confirm that commensal E. coli strains can provide a barrier to infection and suggest that it may be possible to construct E. coli probiotic strains that prevent growth of pathogenic E. coli strains in the intestine.
AbstractList Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect. Immun. 76:1143-1152, 2008). Here, mice were precolonized with any of three human commensal strains (E. coli MG1655, E. coli HS, or E. coli Nissle 1917) and 10 days later were fed 10(5) CFU of the same strains. While each precolonized strain nearly eliminated its isogenic strain, confirming that colonization resistance can be modeled in mice, each allowed growth of the other commensal strains to higher numbers, consistent with different commensal E. coli strains using different nutrients in the intestine. Mice were also precolonized with any of five commensal E. coli strains for 10 days and then were fed 10(5) CFU of E. coli EDL933, an O157:H7 pathogen. E. coli Nissle 1917 and E. coli EFC1 limited growth of E. coli EDL933 in the intestine (10(3) to 10(4) CFU/gram of feces), whereas E. coli MG1655, E. coli HS, and E. coli EFC2 allowed growth to higher numbers (10(6) to 10(7) CFU/gram of feces). Importantly, when E. coli EDL933 was fed to mice previously co-colonized with three E. coli strains (MG1655, HS, and Nissle 1917), it was eliminated from the intestine (<10 CFU/gram of feces). These results confirm that commensal E. coli strains can provide a barrier to infection and suggest that it may be possible to construct E. coli probiotic strains that prevent growth of pathogenic E. coli strains in the intestine.
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy Connect to IAI IAI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0019-9567 Online ISSN: 1098-5522 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to IAI .asm.org, visit: IAI       
Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect. Immun. 76:1143-1152, 2008). Here, mice were precolonized with any of three human commensal strains (E. coli MG1655, E. coli HS, or E. coli Nissle 1917) and 10 days later were fed 105 CFU of the same strains. While each precolonized strain nearly eliminated its isogenic strain, confirming that colonization resistance can be modeled in mice, each allowed growth of the other commensal strains to higher numbers, consistent with different commensal E. coli strains using different nutrients in the intestine. Mice were also precolonized with any of five commensal E. coli strains for 10 days and then were fed 105 CFU of E. coli EDL933, an O157:H7 pathogen. E. coli Nissle 1917 and E. coli EFC1 limited growth of E. coli EDL933 in the intestine (103 to 104 CFU/gram of feces), whereas E. coli MG1655, E. coli HS, and E. coli EFC2 allowed growth to higher numbers (106 to 107 CFU/gram of feces). Importantly, when E. coli EDL933 was fed to mice previously co-colonized with three E. coli strains (MG1655, HS, and Nissle 1917), it was eliminated from the intestine (<10 CFU/gram of feces). These results confirm that commensal E. coli strains can provide a barrier to infection and suggest that it may be possible to construct E. coli probiotic strains that prevent growth of pathogenic E. coli strains in the intestine.
Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect. Immun. 76:1143-1152, 2008). Here, mice were precolonized with any of three human commensal strains ( E. coli MG1655, E. coli HS, or E. coli Nissle 1917) and 10 days later were fed 10 5 CFU of the same strains. While each precolonized strain nearly eliminated its isogenic strain, confirming that colonization resistance can be modeled in mice, each allowed growth of the other commensal strains to higher numbers, consistent with different commensal E. coli strains using different nutrients in the intestine. Mice were also precolonized with any of five commensal E. coli strains for 10 days and then were fed 10 5 CFU of E. coli EDL933, an O157:H7 pathogen. E. coli Nissle 1917 and E. coli EFC1 limited growth of E. coli EDL933 in the intestine (10 3 to 10 4 CFU/gram of feces), whereas E. coli MG1655, E. coli HS, and E. coli EFC2 allowed growth to higher numbers (10 6 to 10 7 CFU/gram of feces). Importantly, when E. coli EDL933 was fed to mice previously co-colonized with three E. coli strains (MG1655, HS, and Nissle 1917), it was eliminated from the intestine (<10 CFU/gram of feces). These results confirm that commensal E. coli strains can provide a barrier to infection and suggest that it may be possible to construct E. coli probiotic strains that prevent growth of pathogenic E. coli strains in the intestine.
Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect. Immun. 76:1143-1152, 2008). Here, mice were precolonized with any of three human commensal strains (E. coli MG1655, E. coli HS, or E. coli Nissle 1917) and 10 days later were fed 10⁵ CFU of the same strains. While each precolonized strain nearly eliminated its isogenic strain, confirming that colonization resistance can be modeled in mice, each allowed growth of the other commensal strains to higher numbers, consistent with different commensal E. coli strains using different nutrients in the intestine. Mice were also precolonized with any of five commensal E. coli strains for 10 days and then were fed 10⁵ CFU of E. coli EDL933, an O157:H7 pathogen. E. coli Nissle 1917 and E. coli EFC1 limited growth of E. coli EDL933 in the intestine (10³ to 10⁴ CFU/gram of feces), whereas E. coli MG1655, E. coli HS, and E. coli EFC2 allowed growth to higher numbers (10⁶ to 10⁷ CFU/gram of feces). Importantly, when E. coli EDL933 was fed to mice previously co-colonized with three E. coli strains (MG1655, HS, and Nissle 1917), it was eliminated from the intestine (<10 CFU/gram of feces). These results confirm that commensal E. coli strains can provide a barrier to infection and suggest that it may be possible to construct E. coli probiotic strains that prevent growth of pathogenic E. coli strains in the intestine.
Author Leatham, Mary P
Cohen, Paul S
Banerjee, Swati
Autieri, Steven M
Mercado-Lubo, Regino
Conway, Tyrrell
AuthorAffiliation Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island 02881, 1 Department of Botany and Microbiology, University of Oklahoma, Norman, Oklahoma 73019 2
AuthorAffiliation_xml – name: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island 02881, 1 Department of Botany and Microbiology, University of Oklahoma, Norman, Oklahoma 73019 2
Author_xml – sequence: 1
  fullname: Leatham, Mary P
– sequence: 2
  fullname: Banerjee, Swati
– sequence: 3
  fullname: Autieri, Steven M
– sequence: 4
  fullname: Mercado-Lubo, Regino
– sequence: 5
  fullname: Conway, Tyrrell
– sequence: 6
  fullname: Cohen, Paul S
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21661358$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19364832$$D View this record in MEDLINE/PubMed
BookMark eNqF0U1v0zAYB_AIDbFucOMM5gAnUvwSv3FA2qqyVhoaUrez5ThOY5TYnZ1u2j4EnxmXVgNOnCzLPz9-Hv9PiiMfvC2K1whOEcLi0_JsOYUQUllC-ayYIChFSSnGR8UEQiRLSRk_Lk5S-pG3VVWJF8UxkoRVguBJ8fN7tCb0wbtH24DFdtAezMIwWJ90D-bJdDY60zkNsnJgNUbtfAIrG-8s0AlocK5jdDaCMYD5dK-uEOWfFxxcxHA_dsB5MHZ2d9duxjA8GOfL62j1mF_8FrbJgqUfbRqdty-L563uk311WE-Lm6_z69mivLy6WM7OLktDCRtLwXVNCLc1w1wj3lQGSt60jYS4FhJhCqVmDGppiSRtVbeCk0Y0mDPGcG0qclp82dfdbOvBNsb6PFivNtENOj6ooJ3698S7Tq3DncIcCkp5LvDhUCCG221uXg0uGdv32ts8kmK8gggR8l-IUSWpoDLDj3toYkgp2vapGwTVLmmVk1a_k1Zwx9_8PcEffIg2g_cHoJPRfRu1Ny49OYwYQ4SK7N7tXefW3b2LVuk0KJd_gHPFFRacZfN2b1odlF7HXOdmhSEiELGKk0qSX0XZx2o
CODEN INFIBR
CitedBy_id crossref_primary_10_1038_s41559_022_01930_9
crossref_primary_10_1016_j_ijmm_2014_10_003
crossref_primary_10_1128_IAI_05820_11
crossref_primary_10_1128_mBio_01628_17
crossref_primary_10_1128_msystems_01383_21
crossref_primary_10_3390_antibiotics4030337
crossref_primary_10_1146_annurev_micro_091014_104115
crossref_primary_10_1080_19490976_2023_2235067
crossref_primary_10_1128_AEM_01866_19
crossref_primary_10_1007_s13213_011_0308_4
crossref_primary_10_1038_s41385_018_0053_0
crossref_primary_10_1016_j_crohns_2014_06_001
crossref_primary_10_1128_microbiolspec_MBP_0006_2014
crossref_primary_10_1371_journal_pone_0280499
crossref_primary_10_1111_cmi_12300
crossref_primary_10_1128_AEM_01686_09
crossref_primary_10_1128_AEM_02166_18
crossref_primary_10_3748_wjg_v29_i11_1651
crossref_primary_10_1128_ecosalplus_esp_0006_2023
crossref_primary_10_1128_IAI_00653_12
crossref_primary_10_1073_pnas_1716241115
crossref_primary_10_3389_fmicb_2018_00947
crossref_primary_10_3390_biology13030142
crossref_primary_10_1016_j_mib_2017_05_007
crossref_primary_10_1038_s41564_017_0095_1
crossref_primary_10_1128_mSphere_00276_20
crossref_primary_10_1152_ajpgi_00261_2022
crossref_primary_10_1128_iai_00206_22
crossref_primary_10_3389_fimmu_2015_00555
crossref_primary_10_1111_j_1574_6976_2012_00328_x
crossref_primary_10_1080_19490976_2022_2068367
crossref_primary_10_3389_fmicb_2021_703421
crossref_primary_10_1007_s10565_021_09587_z
crossref_primary_10_1016_j_micinf_2016_07_005
crossref_primary_10_1080_1745039X_2019_1641376
crossref_primary_10_3109_08910600903444267
crossref_primary_10_1099_mic_0_001175
crossref_primary_10_1146_annurev_genet_120213_092421
crossref_primary_10_1136_gutjnl_2014_309059
crossref_primary_10_3390_v14051110
crossref_primary_10_1089_fpd_2014_1826
crossref_primary_10_1586_14787210_2014_920252
crossref_primary_10_3389_fimmu_2022_1085551
crossref_primary_10_4291_wjgp_v3_i1_27
crossref_primary_10_1093_femsre_fuac008
crossref_primary_10_4049_jimmunol_1403169
crossref_primary_10_1016_j_cub_2020_01_050
crossref_primary_10_1016_j_mib_2017_05_012
crossref_primary_10_3390_ijms22126597
crossref_primary_10_1186_s13015_016_0087_3
crossref_primary_10_1098_rspb_2020_3106
crossref_primary_10_1128_iai_00587_21
crossref_primary_10_1128_IAI_06193_11
crossref_primary_10_1016_j_foodres_2024_114491
crossref_primary_10_1186_s12864_018_5167_y
crossref_primary_10_1016_j_celrep_2015_02_049
crossref_primary_10_1128_mSphere_00847_19
crossref_primary_10_1038_s41522_023_00454_9
crossref_primary_10_1371_journal_pbio_3000617
crossref_primary_10_1146_annurev_micro_020420_013457
crossref_primary_10_1093_femsre_fuaa052
crossref_primary_10_1128_IAI_02943_14
crossref_primary_10_3389_fmicb_2018_00929
crossref_primary_10_1371_journal_pone_0053957
crossref_primary_10_1093_glycob_cwt045
crossref_primary_10_1016_j_tree_2016_03_006
crossref_primary_10_1128_mSphere_00055_15
crossref_primary_10_3390_cancers13050996
crossref_primary_10_3390_microorganisms6040115
crossref_primary_10_1016_j_mib_2010_10_003
crossref_primary_10_1128_iai_00482_23
crossref_primary_10_3389_fvets_2022_937866
crossref_primary_10_3389_fcimb_2023_1237164
crossref_primary_10_1152_ajpgi_00070_2014
crossref_primary_10_1242_dmm_035063
crossref_primary_10_1016_j_otc_2016_08_004
crossref_primary_10_1016_j_ijmm_2012_11_006
crossref_primary_10_1016_j_aninu_2023_06_004
crossref_primary_10_3390_ijms241411688
crossref_primary_10_1038_nri3430
crossref_primary_10_1128_IAI_05395_11
crossref_primary_10_3389_fcimb_2021_716299
crossref_primary_10_1128_mBio_01470_20
crossref_primary_10_5409_wjcp_v2_i4_46
crossref_primary_10_1016_j_chom_2015_08_007
crossref_primary_10_1111_jam_14789
crossref_primary_10_1016_j_molmed_2023_08_006
crossref_primary_10_3390_nu14030527
crossref_primary_10_1073_pnas_1608858113
crossref_primary_10_1016_j_molcel_2020_03_001
crossref_primary_10_1038_s41564_019_0658_4
crossref_primary_10_2217_fmb_2016_0079
crossref_primary_10_1016_j_tim_2012_04_001
crossref_primary_10_1128_IAI_01199_10
crossref_primary_10_3389_fmicb_2019_00977
crossref_primary_10_1080_17474086_2017_1288566
crossref_primary_10_4161_gmic_18754
crossref_primary_10_1093_humupd_dmy012
crossref_primary_10_3390_antibiotics11070875
crossref_primary_10_1371_journal_pone_0022823
crossref_primary_10_1080_10408398_2016_1203286
crossref_primary_10_3390_ani13162577
crossref_primary_10_1371_journal_pcbi_1009341
crossref_primary_10_1097_MPG_0000000000001154
crossref_primary_10_1016_j_medmic_2022_100054
crossref_primary_10_1038_ncomms15028
crossref_primary_10_1038_s41467_022_28163_5
crossref_primary_10_1128_IAI_01435_13
crossref_primary_10_1002_pro_4272
crossref_primary_10_1038_s41598_020_77789_2
crossref_primary_10_1128_JB_00353_19
crossref_primary_10_1111_1462_2920_14380
crossref_primary_10_1093_ibd_izy177
crossref_primary_10_1371_journal_ppat_1000711
crossref_primary_10_1038_s41598_021_81813_4
crossref_primary_10_1371_journal_ppat_1004527
crossref_primary_10_15252_embr_201642282
crossref_primary_10_1186_s12934_020_01465_3
crossref_primary_10_1186_s12866_015_0591_5
crossref_primary_10_3390_ijms161125957
crossref_primary_10_1128_mBio_02237_15
crossref_primary_10_1016_j_chempr_2017_02_001
crossref_primary_10_1038_ismej_2012_164
crossref_primary_10_1371_journal_pone_0050020
crossref_primary_10_1128_AEM_04143_15
crossref_primary_10_1186_1756_0500_7_331
crossref_primary_10_1093_femsle_fnad110
crossref_primary_10_1146_annurev_micro_090816_093549
crossref_primary_10_1038_ni_2608
crossref_primary_10_3390_nu6125786
crossref_primary_10_1128_IAI_00880_10
crossref_primary_10_1038_ncomms10039
crossref_primary_10_1186_s40168_021_01102_0
crossref_primary_10_1128_IAI_01149_13
crossref_primary_10_1089_hs_2020_0010
crossref_primary_10_1016_j_jff_2021_104661
crossref_primary_10_1007_s40588_023_00207_4
crossref_primary_10_1038_s41564_022_01286_7
crossref_primary_10_1111_1462_2920_12019
crossref_primary_10_1038_s41467_023_36337_y
Cites_doi 10.1128/iai.40.1.62-69.1983
10.1007/978-1-4615-9412-3_3
10.1016/j.jbiotec.2005.01.008
10.1146/annurev.mi.31.100177.000431
10.1128/iai.39.2.676-685.1983
10.1046/j.1462-2920.1999.00001.x
10.1128/iai.64.9.3504-3511.1996
10.1006/mpat.1994.1076
10.1128/JB.185.6.1831-1840.2003
10.1128/iai.57.10.3022-3029.1989
10.1128/IAI.01386-07
10.1128/IAI.00052-07
10.1073/pnas.120163297
10.1128/IAI.74.3.1977-1983.2006
10.1128/CDLI.6.3.434-436.1999
10.1016/0022-2836(72)90108-8
10.1128/IAI.71.4.2142-2152.2003
10.1099/mic.0.2006/002006-0
10.1093/oxfordjournals.molbev.a025847
10.1099/00222615-6-4-461
10.1128/iai.39.2.686-703.1983
10.1126/science.277.5331.1453
10.1038/nrmicro818
10.1139/m75-013
10.1128/iai.56.5.1030-1035.1988
10.1128/JB.184.21.5912-5925.2002
10.1016/S0076-6879(95)53026-6
10.1007/s002840010257
10.1017/S0022172400021653
10.1128/JB.186.16.5432-5441.2004
10.1128/iai.64.9.3497-3503.1996
10.1128/iai.58.5.1281-1289.1990
10.1016/0016-5085(90)91241-W
10.1128/IAI.00822-07
10.1128/iai.62.11.5191-5194.1994
10.1073/pnas.0307888101
10.1017/S0950268800047944
10.1007/BF01781204
10.1371/journal.pgen.0040002
10.1093/infdis/113.1.59
10.1128/IAI.72.3.1666-1676.2004
10.1128/iai.58.12.3959-3965.1990
10.1056/NEJM198303243081203
10.1099/mic.0.26396-0
10.1128/jcm.33.6.1602-1605.1995
10.1128/IAI.73.12.8039-8049.2005
10.3181/00379727-86-21030
ContentType Journal Article
Copyright 2009 INIST-CNRS
Copyright © 2009, American Society for Microbiology
Copyright_xml – notice: 2009 INIST-CNRS
– notice: Copyright © 2009, American Society for Microbiology
DBID FBQ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7T7
8FD
C1K
FR3
H94
P64
7X8
5PM
DOI 10.1128/IAI.00059-09
DatabaseName AGRIS
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Research Database
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Technology Research Database


CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-5522
EndPage 2886
ExternalDocumentID 10_1128_IAI_00059_09
19364832
21661358
iai_77_7_2876
US201301647349
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R56 AI048945
– fundername: NIAID NIH HHS
  grantid: AI48945
– fundername: NIAID NIH HHS
  grantid: R01 AI048945
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
18M
29I
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
85S
ABOCM
ACGFO
ADBBV
AENEX
AFMIJ
AGCDD
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CS3
D0S
DIK
DU5
E3Z
EBS
EJD
F5P
FBQ
FRP
GX1
HYE
HZ~
H~9
IH2
J5H
KQ8
L7B
MVM
NEJ
O9-
OHT
OK1
P2P
RHF
RHI
RNS
RPM
RSF
SJN
TR2
TWZ
UCJ
UPT
VH1
VQA
W2D
W8F
WH7
WHG
WOQ
X7M
XFK
Y6R
ZA5
ZGI
ZXP
~KM
08R
AAPBV
AAUGY
H13
IQODW
AGVNZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7T7
8FD
C1K
FR3
H94
P64
7X8
5PM
ID FETCH-LOGICAL-c536t-87ab337eb627a17d4c097dfd902b8912509a660a9e393f4bf873d8d276662bc43
IEDL.DBID RPM
ISSN 0019-9567
IngestDate Tue Sep 17 21:09:19 EDT 2024
Fri Oct 25 22:59:12 EDT 2024
Fri Oct 25 03:26:10 EDT 2024
Fri Dec 06 03:36:14 EST 2024
Sat Nov 02 12:15:07 EDT 2024
Sun Oct 22 16:04:42 EDT 2023
Wed May 18 15:27:11 EDT 2016
Wed Dec 27 19:17:08 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Human
Streptomycin
Microbiology
Digestive system
Colibacillosis
Escherichia coli
Rodentia
Gut
Immunity
Infection
Vertebrata
Antibiotic
Mammalia
Mouse
Aminoglycoside
Bacteriosis
Bacteria
Protein synthesis inhibitor
Antibacterial agent
Enterobacteriaceae
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-87ab337eb627a17d4c097dfd902b8912509a660a9e393f4bf873d8d276662bc43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881. Phone: (401) 874-5920. Fax: (401) 874-2202. E-mail: pco1697u@mail.uri.edu
Editor: B. A. McCormick
OpenAccessLink https://digitalcommons.uri.edu/cgi/viewcontent.cgi?article=1068&context=cmb_facpubs
PMID 19364832
PQID 21495859
PQPubID 23462
PageCount 11
ParticipantIDs pascalfrancis_primary_21661358
crossref_primary_10_1128_IAI_00059_09
proquest_miscellaneous_67401133
fao_agris_US201301647349
highwire_asm_iai_77_7_2876
pubmed_primary_19364832
proquest_miscellaneous_21495859
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2708557
PublicationCentury 2000
PublicationDate 2009-07-01
PublicationDateYYYYMMDD 2009-07-01
PublicationDate_xml – month: 07
  year: 2009
  text: 2009-07-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Infection and Immunity
PublicationTitleAlternate Infect Immun
PublicationYear 2009
Publisher American Society for Microbiology
American Society for Microbiology (ASM)
Publisher_xml – name: American Society for Microbiology
– name: American Society for Microbiology (ASM)
References (e_1_3_2_14_2) 2007
e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_28_2
(e_1_3_2_51_2) 2008; 6
e_1_3_2_41_2
e_1_3_2_43_2
e_1_3_2_62_2
e_1_3_2_45_2
(e_1_3_2_21_2) 1988
e_1_3_2_24_2
e_1_3_2_47_2
(e_1_3_2_32_2) 1983
e_1_3_2_60_2
(e_1_3_2_5_2) 1996; 2
e_1_3_2_9_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_54_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_52_2
e_1_3_2_12_2
e_1_3_2_58_2
e_1_3_2_3_2
(e_1_3_2_22_2) 1992
e_1_3_2_35_2
e_1_3_2_56_2
e_1_3_2_50_2
(e_1_3_2_48_2) 1998
e_1_3_2_27_2
e_1_3_2_29_2
(e_1_3_2_20_2) 1983
e_1_3_2_42_2
e_1_3_2_63_2
e_1_3_2_23_2
e_1_3_2_44_2
(e_1_3_2_13_2) 2005
e_1_3_2_25_2
e_1_3_2_46_2
e_1_3_2_61_2
(e_1_3_2_40_2) 1978; 1
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
(e_1_3_2_37_2) 2005
e_1_3_2_17_2
e_1_3_2_59_2
e_1_3_2_6_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_11_2
(e_1_3_2_33_2) 1984; 14
e_1_3_2_34_2
e_1_3_2_57_2
e_1_3_2_4_2
e_1_3_2_36_2
e_1_3_2_2_2
(e_1_3_2_55_2) 2005; 21
References_xml – ident: e_1_3_2_12_2
  doi: 10.1128/iai.40.1.62-69.1983
– ident: e_1_3_2_39_2
  doi: 10.1007/978-1-4615-9412-3_3
– ident: e_1_3_2_56_2
  doi: 10.1016/j.jbiotec.2005.01.008
– ident: e_1_3_2_19_2
  doi: 10.1146/annurev.mi.31.100177.000431
– ident: e_1_3_2_23_2
  doi: 10.1128/iai.39.2.676-685.1983
– start-page: 33
  year: 1983
  ident: e_1_3_2_20_2
  publication-title: Human intestinal microflora in health and disease
– ident: e_1_3_2_41_2
  doi: 10.1046/j.1462-2920.1999.00001.x
– ident: e_1_3_2_58_2
  doi: 10.1128/iai.64.9.3504-3511.1996
– ident: e_1_3_2_49_2
  doi: 10.1006/mpat.1994.1076
– ident: e_1_3_2_17_2
  doi: 10.1128/JB.185.6.1831-1840.2003
– ident: e_1_3_2_42_2
  doi: 10.1128/iai.57.10.3022-3029.1989
– ident: e_1_3_2_18_2
  doi: 10.1128/IAI.01386-07
– ident: e_1_3_2_27_2
  doi: 10.1128/IAI.00052-07
– ident: e_1_3_2_16_2
  doi: 10.1073/pnas.120163297
– ident: e_1_3_2_26_2
  doi: 10.1128/IAI.74.3.1977-1983.2006
– ident: e_1_3_2_53_2
  doi: 10.1128/CDLI.6.3.434-436.1999
– ident: e_1_3_2_25_2
  doi: 10.1016/0022-2836(72)90108-8
– ident: e_1_3_2_44_2
– ident: e_1_3_2_47_2
  doi: 10.1128/IAI.71.4.2142-2152.2003
– ident: e_1_3_2_34_2
  doi: 10.1099/mic.0.2006/002006-0
– ident: e_1_3_2_6_2
  doi: 10.1093/oxfordjournals.molbev.a025847
– volume: 6
  start-page: 417
  year: 2008
  ident: e_1_3_2_51_2
  publication-title: Cell Host Microbe
– ident: e_1_3_2_2_2
  doi: 10.1099/00222615-6-4-461
– ident: e_1_3_2_24_2
  doi: 10.1128/iai.39.2.686-703.1983
– ident: e_1_3_2_7_2
  doi: 10.1126/science.277.5331.1453
– start-page: 175
  year: 2007
  ident: e_1_3_2_14_2
  publication-title: Virulence mechanisms of bacterial pathogens
– ident: e_1_3_2_15_2
– ident: e_1_3_2_35_2
  doi: 10.1038/nrmicro818
– ident: e_1_3_2_59_2
  doi: 10.1139/m75-013
– ident: e_1_3_2_62_2
  doi: 10.1128/iai.56.5.1030-1035.1988
– ident: e_1_3_2_31_2
  doi: 10.1128/JB.184.21.5912-5925.2002
– start-page: 111
  year: 1992
  ident: e_1_3_2_22_2
  publication-title: Probiotics: the scientific basis
– start-page: 199
  year: 2005
  ident: e_1_3_2_37_2
  publication-title: Colonization of mucosal surfaces
– ident: e_1_3_2_11_2
  doi: 10.1016/S0076-6879(95)53026-6
– volume: 1
  start-page: 1119
  year: 1978
  ident: e_1_3_2_40_2
  publication-title: Lancet
– start-page: 311
  year: 1983
  ident: e_1_3_2_32_2
  publication-title: Human intestinal microflora in health and disease
– ident: e_1_3_2_60_2
  doi: 10.1007/s002840010257
– ident: e_1_3_2_61_2
  doi: 10.1017/S0022172400021653
– ident: e_1_3_2_30_2
  doi: 10.1128/JB.186.16.5432-5441.2004
– ident: e_1_3_2_57_2
  doi: 10.1128/iai.64.9.3497-3503.1996
– volume: 2
  start-page: 2460
  year: 1996
  ident: e_1_3_2_5_2
  publication-title: Escherichia coli and Salmonella typhimurium: cellular and molecular biology
– ident: e_1_3_2_46_2
  doi: 10.1128/iai.58.5.1281-1289.1990
– ident: e_1_3_2_29_2
  doi: 10.1016/0016-5085(90)91241-W
– ident: e_1_3_2_4_2
  doi: 10.1128/IAI.00822-07
– start-page: 357
  year: 1998
  ident: e_1_3_2_48_2
  publication-title: Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains
– ident: e_1_3_2_52_2
  doi: 10.1128/iai.62.11.5191-5194.1994
– ident: e_1_3_2_10_2
  doi: 10.1073/pnas.0307888101
– ident: e_1_3_2_3_2
  doi: 10.1017/S0950268800047944
– volume: 21
  start-page: 44
  year: 2005
  ident: e_1_3_2_55_2
  publication-title: Curr. Opin. Gastroenterol.
– ident: e_1_3_2_8_2
  doi: 10.1007/BF01781204
– ident: e_1_3_2_28_2
  doi: 10.1371/journal.pgen.0040002
– ident: e_1_3_2_43_2
  doi: 10.1093/infdis/113.1.59
– ident: e_1_3_2_45_2
  doi: 10.1128/IAI.72.3.1666-1676.2004
– ident: e_1_3_2_63_2
  doi: 10.1128/iai.58.12.3959-3965.1990
– start-page: 45
  year: 1988
  ident: e_1_3_2_21_2
  publication-title: Virulence mechanisms of bacterial pathogens.
– start-page: 17
  year: 2005
  ident: e_1_3_2_13_2
  publication-title: Colonization of mucosal surfaces
– ident: e_1_3_2_54_2
  doi: 10.1056/NEJM198303243081203
– ident: e_1_3_2_50_2
  doi: 10.1099/mic.0.26396-0
– volume: 14
  start-page: 53
  year: 1984
  ident: e_1_3_2_33_2
  publication-title: Microecol. Theor.
– ident: e_1_3_2_36_2
  doi: 10.1128/jcm.33.6.1602-1605.1995
– ident: e_1_3_2_38_2
  doi: 10.1128/IAI.73.12.8039-8049.2005
– ident: e_1_3_2_9_2
  doi: 10.3181/00379727-86-21030
SSID ssj0014448
Score 2.4223342
Snippet Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the...
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
highwire
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2876
SubjectTerms Animals
Anti-Bacterial Agents - administration & dosage
Antibiosis
Bacterial Infections
Bacteriology
Biological and medical sciences
Colony Count, Microbial
Escherichia coli
Escherichia coli - classification
Escherichia coli - growth & development
Feces - microbiology
Fundamental and applied biological sciences. Psychology
Humans
Intestines - microbiology
Mice
Microbiology
Miscellaneous
Streptomycin - administration & dosage
Title Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine
URI http://iai.asm.org/content/77/7/2876.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19364832
https://search.proquest.com/docview/21495859
https://search.proquest.com/docview/67401133
https://pubmed.ncbi.nlm.nih.gov/PMC2708557
Volume 77
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa6lUBcUCmPpsDiAxyzm9hObHMr1ZZd0EKldqXeLCdxaKRusmrSQ_kR_c3M5FG6CC6cM4kVf-PxjOfzDCHvWejy0DFkT2XCF9KGfiKt9hV2HOURF1biBeflt3i-El8uoosdEg13YVrSfpoUk_JqPSmLy5ZbuVmn04EnNj1dHjOJ7Co5HZERbL9DiN6nDoQQvfnVPjj_cmC7MzVdHC0mbUUSP-iqhfJYKM62tqRRbqsHxYKRK2lrmK6863PxN0f0Tz7lgw3qZI887T1LetT9wTOy48p98qjrNXm7Tx4v-yz6c3J3imHwFazmny6j7TE-xYsiENHCB2Y14lggB5qCVEHP2jYSNUWz4qitqaWf7DV2uqNNRWeTTup7GMmPc0k_Q1zfXNKipOBa4rtu01TrWxjZP0cHFUZcVje1o3gWCfaldC_I6mR2fjz3-74MfhrxuAEDahPOsZkKA2xlJtJAyyzPdMASpcFjCrSN48BqxzXPRZIryTOVMQmhEktSwV-S3bIq3QGhyMJxaS5VHmUiVJl2YSxdFNs8SlCLPPJhgMZsuvIbpg1bmDKApmnRNIH2yAHgZuwPsIxmdcYwH4uV0riAR4cDmMbWa1PYwkhppIFYMfbIeAve-0FYCI4Lj5RH3g14G1h4mE2xpYNpAgmILVWk_y0RY7fDkHOPvOr04_cv9JrnEbmlOfcCWPR7-wmshbb4d6_7h__95mvypMuIIeX4Ddltrm_cW3CsmmQMIcXi67hdTr8AXMUgWg
link.rule.ids 230,314,727,780,784,885,27924,27925,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIqAXBOXRFGh9gGN2Ez_imFuptuxCt1TqrtSb5SQOjdTNrpr00P4IfjMzeZQuggtnT2I533g8k_k8Q8gHFro8dAzZU5nwhbKhnyir_Rg7jnLJhVV4wXl6Go3n4uuFvNggsr8L05D206QYlFeLQVlcNtzK1SId9jyx4dn0iClkV6nhJnkkudJhH6R3yQMhRGeAtQ_uv-r57iweTg4ng6YmiR-09UJ5JGLO1g6lzdwuH5QLRrakreCD5W2ni7-5on8yKh8cUcfPybPOt6SH7RpekA1X7pDHbbfJ2x3yZNrl0V-Sn2cYCF_Bfr5zGW1-5FO8KgIxLbxgVCGSBbKgKUgV9LxpJFFRNCyO2opa-tleY687Wi_paNBKfQ-l-jRW9AtE9vUlLUoKziU-61b1cnELM_szdFFhxunypnIU_0aChSndKzI_Hs2Oxn7XmcFPJY9qMKE24RzbqTBAV2UiDbTK8kwHLIk1-EyBtlEUWO245rlI8ljxLM6YgmCJJangr8lWuSzdLqHIw3FpruJcZiKMM-3CSDkZ2VwmqEce-dhDY1ZtAQ7TBC4sNoCmadA0gfbILuBm7A-wjWZ-zjAji7XSuIChvR5MY6uFKWxhlDLKQLQYeWR_Dd77SVgIrguXsUcOerwNbD3Mp9jSwWcCCYguY6n_LRFhv8OQc4-8afXj9xI6zfOIWtOcewEs-70-AruhKf_daf_efz95QJ6OZ9MTczI5_faWbLf5MSQgvyNb9fWNew9uVp3sN5vqF9xMIrY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVoERUXBAXaFGh9gGN2E9uJbW6ldNkFtqzUrtSb5SQOjdTNrpr0UH4Ev5mZfJRdBBfOmcRy3sx4JvMyQ8hbFro8dAzZU5nwhbShn0irfYUTR3nEhZX4g_P0LB7PxefL6HJt1FdD2k-TYlBeLwZlcdVwK1eLdNjzxIaz6QmTyK6Sw1WWD7fIw4iDkvWJeldAEEJ0Tlj7kALInvPO1HByPBk0fUn8oO0ZymOhONs4mLZyu1xrGYyMSVvBS8vbaRd_C0f_ZFWuHVOjp-RJF1_S43Yfz8gDV-6SR-3EybtdsjPtaunPyc8ZJsPXYNM_XEabj_kUfxeBvBYecFohmgUyoSlIFfS8GSZRUXQujtqKWvrB3uC8O1ov6emglfoWRvL9WNJPkN3XV7QoKQSYeK9b1cvFHazsX2CYCitOl7eVo_hFErxM6V6Q-ej04mTsd9MZ_DTicQ1u1Cac40gVBgjLTKSBllme6YAlSkPcFGgbx4HVjmueiyRXkmcqYxISJpakgr8k2-WydPuEIhfHpblUeZSJUGXahbF0UWzzKEFd8si7HhqzaptwmCZ5YcoAmqZB0wTaI_uAm7HfwT-a-TnDqiz2S-MCLh30YBpbLUxhCyOlkQYyxtgjhxvw3i_CQghfeKQ8ctTjbcD8sKZiSwevCSQgw1SR_rdEjDMPQ849stfqx-8tdJrnEbmhOfcC2Pp78wpYRNMCvLOAg_--84jszD6OzNfJ2ZdX5HFbIkMO8muyXd_cujcQadXJYWNTvwALPiPJ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Precolonized+human+commensal+Escherichia+coli+strains+serve+as+a+barrier+to+E.+coli+O157%3AH7+growth+in+the+streptomycin-treated+mouse+intestine&rft.jtitle=Infection+and+immunity&rft.au=Leatham%2C+Mary+P&rft.au=Banerjee%2C+Swati&rft.au=Autieri%2C+Steven+M&rft.au=Mercado-Lubo%2C+Regino&rft.date=2009-07-01&rft.eissn=1098-5522&rft.volume=77&rft.issue=7&rft.spage=2876&rft.epage=2886&rft_id=info:doi/10.1128%2FIAI.00059-09&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon